The TCLs from these apoptotic cancer cells effectively activated monocyte-derived DCs, showing significantly facilitated gene expression levels of IL-12 and IL-6 cytokines compared to TCLs from lipopolysaccharide (LPS)-treated cancer cells. The gene discussed is IL6; the disease is cancer.